Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Nov;70(11):1221-1229.
doi: 10.1038/ejcn.2016.78. Epub 2016 May 18.

Liver-related safety assessment of green tea extracts in humans: a systematic review of randomized controlled trials

T Isomura  1   2   3   4 , S Suzuki  3 , H Origasa  4 , A Hosono  3 , M Suzuki  1 , T Sawada  1 , S Terao  1 , Y Muto  1 , T Koga  1
Affiliations

Liver-related safety assessment of green tea extracts in humans: a systematic review of randomized controlled trials

T Isomura et al. Eur J Clin Nutr. 2016 Nov.

Erratum in

Abstract

There remain liver-related safety concerns, regarding potential hepatotoxicity in humans, induced by green tea intake, despite being supposedly beneficial. Although many randomized controlled trials (RCTs) of green tea extracts have been reported in the literature, the systematic reviews published to date were only based on subjective assessment of case reports. To more objectively examine the liver-related safety of green tea intake, we conducted a systematic review of published RCTs. A systematic literature search was conducted using three databases (PubMed, EMBASE and Cochrane Central Register of Controlled Trials) in December 2013 to identify RCTs of green tea extracts. Data on liver-related adverse events, including laboratory test abnormalities, were abstracted from the identified articles. Methodological quality of RCTs was assessed. After excluding duplicates, 561 titles and abstracts and 119 full-text articles were screened, and finally 34 trials were identified. Of these, liver-related adverse events were reported in four trials; these adverse events involved seven subjects (eight events) in the green tea intervention group and one subject (one event) in the control group. The summary odds ratio, estimated using a meta-analysis method for sparse event data, for intervention compared with placebo was 2.1 (95% confidence interval: 0.5-9.8). The few events reported in both groups were elevations of liver enzymes. Most were mild, and no serious liver-related adverse events were reported. Results of this review, although not conclusive, suggest that liver-related adverse events after intake of green tea extracts are expected to be rare.

PubMed Disclaimer

Conflict of interest statement

TI is a founder and the chief executive of Clinical Study Support Inc. TS and ST are current employees of Clinical Study Support Inc. MS and YM were previously employed by Clinical Study Support Inc. TK is a member of an advisory board of the company. The remaining authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Flowchart of study selection.
Figure 2
Figure 2
Risk of bias assessment.
Figure 3
Figure 3
Meta-analysis of reported liver-related adverse events. Note: the size of the square is proportional to the weight of the study.
See this image and copyright information in PMC

References

    1. Katiyar S, Mukhtar H. Tea in chemoprevention of cancer. Int J Oncol 1996; 8: 221–238. - PubMed
    1. Henning SM, Fajardo-Lira C, Lee HW, Youssefian AA, Go VL, Heber D. Catechin content of 18 teas and a green tea extract supplement correlates with the antioxidant capacity. Nutr Cancer 2003; 45: 226–235. - PubMed
    1. Sarma DN, Barrett ML, Chavez ML, Gardiner P, Ko R. Safety of green tea extracts: a systematic review by the US Pharmacopeia. Drug Saf 2008; 31: 469–484. - PubMed
    1. Gloro R, Hourmand-Ollivier I, Mosquet B, Mosquet L, Rousselot P, Salamé E et al. Fulminant hepatitis during self-medication with hydroalcoholic extract of green tea. Eur J Gastroenterol Hepatol 2005; 17: 1135–1137. - PubMed
    1. Galati G, Lin A, Sultan AM, O'Brien PJ. Cellular and in vivo hepatotoxicity caused by green tea phenolic acids and catechins. Free Radic Biol Med 2006; 40: 570–580. - PubMed

Publication types